• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

NIHR Oxford Health Biomedical Research Centre

Improving brain health: the future in mind

MENUMENU
  • About
    • About
    • Management and core team
    • Our partners
    • Timeline of our key achievements
    • Core facilities
    • Work with us
    • Contact
  • Departments
    • NIHR Oxford Cognitive Health Clinical Research Facility
    • Brain Health Centre
    • Oxford Precision Psychiatry Lab (OxPPL)
    • Oxford Dementia and Ageing Research (OxDARE)
    • Treatment Resistant Depression Clinic
    • Experimental Medicine and Industry Partnership (EMIP)
  • Research Themes
    • Better Sleep
    • Brain Technologies
    • Data Science
    • Dementia
    • Depression Therapeutics
    • Flourishing & Wellbeing
    • Mental Health in Development
    • Molecular Targets
    • Pain
    • Preventing Multiple Morbidities
    • Psychological Treatments
  • COVID-19 Research
    • Overview
    • News
    • COVID-19 & clinical management of mental health issues
  • News & Events
    • News
    • Blog
    • Training & Events
    • Psychiatry department seminars
  • Training Hub
  • Patients & Public
    • About Patient and Public Involvement
    • Shape our research
    • Take part in our research
    • Resources for researchers
    • Resources for the public
    • Patient and Public Involvement Strategy
    • Young people’s involvement
You are here: Home / News / Link between calcium abnormality and bipolar disorder

Link between calcium abnormality and bipolar disorder

19th December 2019

Calcium ions play a critical role in how brain cells work, and it has long been suspected that an abnormality in calcium might contribute to bipolar disorder. However, findings have been variable and no conclusions could be drawn.

Now, researchers led by Professor Paul Harrison have performed a systematic review of all the evidence and shown clearly that there is a higher concentration of calcium ions in cells from patients with bipolar disorder than in cells from healthy subjects. A total of 21 studies involving 642 patients and 404 control subjects were included in the review.

This difference is seen in all phases of the illness, and is not due to medication. The result supports the possibility that drugs which target calcium ions might be of value in treating bipolar disorder, a possibility which is being investigated in other studies within the Oxford Health BRC.

Read the full paper here.

Filed Under: News

Primary Sidebar

Tweets by OxHealthBRC
Follow @OxHealthBRC

Post categories

Footer

Follow us

  • Twitter
  • YouTube

Improving brain health: the future in mind

The National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) is a partnership between Oxford Health NHS Foundation Trust and the University of Oxford.  We are part of the Oxford Academic Health Partners.
Oxford Academic Health Partners
  • Sitemap
  • Accessibility
  • Disclaimer
  • Cookies
  • Contact

© 2023 NIHR Oxford Health Biomedical Research Centre · Log in

Cookies

This site uses cookies: See our privacy policy